FKW 00GA

Drug Profile

FKW 00GA

Alternative Names: FKW00GA; TGW 00AA; TGW00AA HCl; TGWOOAA; TGWOOAA HCl

Latest Information Update: 28 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unknown
  • Developer Fabre-Kramer Pharmaceuticals
  • Class Anxiolytics
  • Mechanism of Action Serotonin 1A receptor agonists; Serotonin 2A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Generalised anxiety disorder; Social phobia
  • No development reported Anxiety disorders

Most Recent Events

  • 28 Jan 2018 No recent reports of development identified for preclinical development in Anxiety-disorders in USA (PO, Controlled release)
  • 08 Jan 2016 Phase II development is ongoing for Social phobia and Generalised anxiety disorder in USA
  • 08 Jan 2016 Preclinical development for Anxiety disorders is ongoing in USA (controlled release formulation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top